Micha Zimmerman
Profile
Micha Zimmerman is the founder of CyOptics, Inc. which was founded in 1999.
He held the title of Vice President-Research & Development from 2009 to 2011.
Dr. Zimmerman also worked as a Principal at SCD.
He received a doctorate degree from Princeton University and an undergraduate degree from Technion-Israel Institute of Technology.
Former positions of Micha Zimmerman
| Companies | Position | End |
|---|---|---|
SCD
 SCD Miscellaneous Commercial ServicesCommercial Services SCD is an enzyme that catalyzes fatty acid desaturation, which is incorporated into various lipid-related molecules that regulate multiple cellular properties and processes. The private company is based in Madrid, Spain. SCD expression is regulated by a transcription factor known as SREBF1, which has been identified as a risk factor for Parkinson's disease. In preclinical models, SCD inhibition appears to improve neuronal function and reduce toxicity, leading to enhanced neuronal survival. The disruption of membrane-related biological pathways, such as vesicle trafficking, is closely linked to the formation of Lewy body protein/membrane aggregations, a hallmark pathological feature of Parkinson's disease. | Corporate Officer/Principal | - |
CyOptics, Inc.
 CyOptics, Inc. Electronic ComponentsElectronic Technology CyOptics, Inc. designs, develops and markets optical chips and components. It designs, develops and markets a line of InP optical chips and components for integration into access, metro and long-haul communications systems. The firm also provides contract design, foundry and packaging services. The company was founded by Uzi Koren, Micah Zimmerman, Mansur Roni and Yair Halpren in January 1999 and is headquartered in Allentown, PA. | Founder | 2011-08-17 |
Training of Micha Zimmerman
| Princeton University | Doctorate Degree |
| Technion-Israel Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
SCD
SCD Miscellaneous Commercial ServicesCommercial Services SCD is an enzyme that catalyzes fatty acid desaturation, which is incorporated into various lipid-related molecules that regulate multiple cellular properties and processes. The private company is based in Madrid, Spain. SCD expression is regulated by a transcription factor known as SREBF1, which has been identified as a risk factor for Parkinson's disease. In preclinical models, SCD inhibition appears to improve neuronal function and reduce toxicity, leading to enhanced neuronal survival. The disruption of membrane-related biological pathways, such as vesicle trafficking, is closely linked to the formation of Lewy body protein/membrane aggregations, a hallmark pathological feature of Parkinson's disease. | Commercial Services |
CyOptics, Inc.
CyOptics, Inc. Electronic ComponentsElectronic Technology CyOptics, Inc. designs, develops and markets optical chips and components. It designs, develops and markets a line of InP optical chips and components for integration into access, metro and long-haul communications systems. The firm also provides contract design, foundry and packaging services. The company was founded by Uzi Koren, Micah Zimmerman, Mansur Roni and Yair Halpren in January 1999 and is headquartered in Allentown, PA. | Electronic Technology |
- Stock Market
- Insiders
- Micha Zimmerman
